IE39216L - Pharmaceutical tablets - Google Patents
Pharmaceutical tabletsInfo
- Publication number
- IE39216L IE39216L IE740803A IE80374A IE39216L IE 39216 L IE39216 L IE 39216L IE 740803 A IE740803 A IE 740803A IE 80374 A IE80374 A IE 80374A IE 39216 L IE39216 L IE 39216L
- Authority
- IE
- Ireland
- Prior art keywords
- tablets
- weight
- pharmaceutical tablets
- penicillins
- pharmaceutical
- Prior art date
Links
- 229930182555 Penicillin Natural products 0.000 abstract 3
- -1 propacillin Chemical compound 0.000 abstract 3
- 150000002960 penicillins Chemical class 0.000 abstract 2
- 101100234822 Caenorhabditis elegans ltd-1 gene Proteins 0.000 abstract 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 abstract 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 1
- 229960003022 amoxicillin Drugs 0.000 abstract 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 abstract 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 abstract 1
- 229960000723 ampicillin Drugs 0.000 abstract 1
- ODFHGIPNGIAMDK-NJBDSQKTSA-N azidocillin Chemical compound C1([C@@H](N=[N+]=[N-])C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 ODFHGIPNGIAMDK-NJBDSQKTSA-N 0.000 abstract 1
- 229960004328 azidocillin Drugs 0.000 abstract 1
- 229960003669 carbenicillin Drugs 0.000 abstract 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 abstract 1
- 229940106164 cephalexin Drugs 0.000 abstract 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 abstract 1
- 229960003326 cloxacillin Drugs 0.000 abstract 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 abstract 1
- YFAGHNZHGGCZAX-JKIFEVAISA-N dicloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl YFAGHNZHGGCZAX-JKIFEVAISA-N 0.000 abstract 1
- 229960001585 dicloxacillin Drugs 0.000 abstract 1
- 238000007907 direct compression Methods 0.000 abstract 1
- 229960002457 epicillin Drugs 0.000 abstract 1
- RPBAFSBGYDKNRG-NJBDSQKTSA-N epicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CCC=CC1 RPBAFSBGYDKNRG-NJBDSQKTSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960004273 floxacillin Drugs 0.000 abstract 1
- 229960003884 hetacillin Drugs 0.000 abstract 1
- DXVUYOAEDJXBPY-NFFDBFGFSA-N hetacillin Chemical compound C1([C@@H]2C(=O)N(C(N2)(C)C)[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 DXVUYOAEDJXBPY-NFFDBFGFSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract 1
- 239000001095 magnesium carbonate Substances 0.000 abstract 1
- 229960003806 metampicillin Drugs 0.000 abstract 1
- FZECHKJQHUVANE-MCYUEQNJSA-N metampicillin Chemical compound C1([C@@H](N=C)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 FZECHKJQHUVANE-MCYUEQNJSA-N 0.000 abstract 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 abstract 1
- 229940049954 penicillin Drugs 0.000 abstract 1
- NONJJLVGHLVQQM-JHXYUMNGSA-N phenethicillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C(C)OC1=CC=CC=C1 NONJJLVGHLVQQM-JHXYUMNGSA-N 0.000 abstract 1
- 229960004894 pheneticillin Drugs 0.000 abstract 1
- 229960003342 pivampicillin Drugs 0.000 abstract 1
- ZEMIJUDPLILVNQ-ZXFNITATSA-N pivampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)[C@H](C(S3)(C)C)C(=O)OCOC(=O)C(C)(C)C)=CC=CC=C1 ZEMIJUDPLILVNQ-ZXFNITATSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960002780 talampicillin Drugs 0.000 abstract 1
- SOROUYSPFADXSN-SUWVAFIASA-N talampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(=O)OC2C3=CC=CC=C3C(=O)O2)(C)C)=CC=CC=C1 SOROUYSPFADXSN-SUWVAFIASA-N 0.000 abstract 1
- 229960004659 ticarcillin Drugs 0.000 abstract 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1422176 Pharmaceutical tablets BEECHAM GROUP Ltd 1 May 1974 [5 May 1973 7 Dec 1973] 21502/73 and 56858/73 Heading A5B Pharmaceutical tablets comprise 10% to 70% by weight of heavy magnesium carbonate, 30% to 85% by weight of a semi-synthetic penicillin or cephalosparin which is suitable for oral administration and 0 to 40% by weight of conventional tabletting ingredients. The tablets may be produced by direct compression in a tablet press. Two different penicillins may be present in the tablets. The penicillins and cephalosparins may be cloxacillin, flucloxacillin, dicloxacillin, an α-ester of carbenicillin or ticarcillin, phenethicillin, propacillin, azidocillin, hetacillin, metampicillin, cyclocillin, epicillin, pivampicillin, talampicillin, cephalexin, cephadrine, ampicillin, amoxycillin and esters and salts thereof.
[GB1422176A]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2150273A GB1422176A (en) | 1973-05-05 | 1973-05-05 | Pharmaceutical tablets |
| GB5685873 | 1973-12-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE39216L true IE39216L (en) | 1974-11-05 |
| IE39216B1 IE39216B1 (en) | 1978-08-30 |
Family
ID=26255363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE803/74A IE39216B1 (en) | 1973-05-05 | 1974-04-17 | Pharmaceutical tablets |
Country Status (10)
| Country | Link |
|---|---|
| JP (1) | JPS5714649B2 (en) |
| CA (1) | CA1018890A (en) |
| DE (1) | DE2421273A1 (en) |
| DK (1) | DK145712C (en) |
| FR (1) | FR2227856B1 (en) |
| GB (1) | GB1422176A (en) |
| IE (1) | IE39216B1 (en) |
| IL (1) | IL44646A (en) |
| NL (1) | NL7406023A (en) |
| SE (1) | SE402405B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE48715B1 (en) * | 1978-12-22 | 1985-05-01 | Elan Corp Plc | New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same |
| DE3239592C2 (en) * | 1982-10-26 | 1986-10-30 | Institut organičeskogo sinteza Akademii Nauk Latvijskoj SSR, Riga | Antibacterial drug |
| ES2019583B3 (en) * | 1985-10-19 | 1991-07-01 | Beecham Group Plc | COMPOSITION FOR THE TREATMENT OF INFECTIONS. |
| US6749864B2 (en) | 1986-02-13 | 2004-06-15 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
| US5433959A (en) * | 1986-02-13 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
| CA1327010C (en) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| GB9613470D0 (en) | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
| IS7724A (en) * | 2005-03-02 | 2006-09-03 | Actavis Group | Composition of tablets with rapid decomposition containing heavy magnesium carbonate |
| EP1728511A1 (en) * | 2005-05-31 | 2006-12-06 | Faust Pharmaceuticals | New use of phenethicillin and salts thereof. |
| PT2531178E (en) * | 2010-02-03 | 2014-09-12 | Merck Patent Gmbh | Directly compressible magnesium hydroxide carbonate |
| WO2012124827A1 (en) * | 2011-03-17 | 2012-09-20 | 協和化学工業株式会社 | Binder for tablet forming |
-
1973
- 1973-05-05 GB GB2150273A patent/GB1422176A/en not_active Expired
-
1974
- 1974-04-16 IL IL44646A patent/IL44646A/en unknown
- 1974-04-17 IE IE803/74A patent/IE39216B1/en unknown
- 1974-04-26 FR FR7414543A patent/FR2227856B1/fr not_active Expired
- 1974-04-26 SE SE7405687A patent/SE402405B/en unknown
- 1974-05-02 DE DE2421273A patent/DE2421273A1/en not_active Withdrawn
- 1974-05-03 CA CA198,938A patent/CA1018890A/en not_active Expired
- 1974-05-03 DK DK243274A patent/DK145712C/en not_active IP Right Cessation
- 1974-05-03 NL NL7406023A patent/NL7406023A/xx not_active Application Discontinuation
- 1974-05-07 JP JP5066074A patent/JPS5714649B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5029732A (en) | 1975-03-25 |
| DK145712C (en) | 1983-07-25 |
| GB1422176A (en) | 1976-01-21 |
| JPS5714649B2 (en) | 1982-03-25 |
| CA1018890A (en) | 1977-10-11 |
| FR2227856A1 (en) | 1974-11-29 |
| DE2421273A1 (en) | 1974-11-14 |
| IE39216B1 (en) | 1978-08-30 |
| DK145712B (en) | 1983-02-07 |
| FR2227856B1 (en) | 1978-02-03 |
| IL44646A0 (en) | 1974-06-30 |
| NL7406023A (en) | 1974-11-07 |
| SE402405B (en) | 1978-07-03 |
| AU6853574A (en) | 1975-11-06 |
| IL44646A (en) | 1977-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE39216B1 (en) | Pharmaceutical tablets | |
| GB1508977A (en) | Beta-lactam antibiotic from streptomyces clavuligerus | |
| IE36461B1 (en) | Penicillins | |
| EP0318377A3 (en) | Enantiomeric derivatives of amino acids, process for their preparation and their pharmaceutical applications | |
| GB1471564A (en) | Direct compression tabletting composition and tablets produced therefrom | |
| GB1359643A (en) | Controlled release medicament | |
| GB1380171A (en) | Medicinal tablets | |
| EP0312813A3 (en) | Preparation of clavulanic acid and its salts and esters | |
| GB1204580A (en) | Pharmaceutical dosage forms | |
| GR3017547T3 (en) | Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient. | |
| GB1426484A (en) | Cis-20-deethy-eburnamonine | |
| IE39741L (en) | Phenyl-benzoic acid pharmaceuticals | |
| CA2147759A1 (en) | Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it | |
| IE810452L (en) | Orally administrable drug form | |
| GB1439240A (en) | Chewable aspirin tablet | |
| GB1504426A (en) | Clavulanic acid derivatives | |
| GB1262830A (en) | Novel sydnonimine derivative | |
| GB1417539A (en) | Pyrazolo-qzinoline derivative and compositions thereof | |
| EP0002319B1 (en) | Clavulanic acid derivatives, a process for their preparation and compositions containing them | |
| IL42201A (en) | 2-((1-benzylcyclopentyl)-imino)pyrrolidine | |
| PT84580A (en) | Process for the preparation of pharmaceutical compositions containing indomethacin | |
| GB1375806A (en) | ||
| GB1368251A (en) | Theophylinylmethylethanoic acid ester | |
| US3888848A (en) | Ampicillin-chloral hydrate complex | |
| GB1275164A (en) | New heterocyclic carboxylic acids, process for their production and pharmaceutical preparations having a content thereof |